Add BrightSurf on Google Email

Researchers identify new drug target to prevent development of dangerous blood vessel defects in brain

Researchers have identified TIE2 as a crucial link between two signaling pathways that drive the growth of blood vessel abnormalities in the brain. Inhibiting TIE2 with a small drug called rebastinib may provide an endothelial cell-centered approach to prevent CCMs, which can cause brain hemorrhages and seizures.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·TypeExperimental study·DateMar 27, 2026

An international team led by the Universitat Politècnica de València has developed one of the most detailed brain atlases in the world

An international team led by Universitat Politècnica de València has developed HoliAtlas, a highly detailed structural atlas of the human brain. This comprehensive map will aid in studying neurological diseases, including Alzheimer's and Parkinson's, and enable more accurate diagnoses.

SourceUniversitat Politècnica de València·JournalScientific Reports·TypeImaging analysis·DateMar 24, 2026

Severe infections may raise dementia risk, study finds

A Finnish registry study found that severe infections, such as cystitis and bacterial disease, are associated with an increased risk of dementia. The study examined nationwide health registry data and identified 29 diseases linked to dementia risk, including mental disorders, Parkinson's disease, and alcohol-related mental disorders.

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateMar 24, 2026

Improving heart health may not be enough to protect against Alzheimer’s disease

Researchers found that exercise and aggressive cardiovascular risk reduction improved heart health, but did not produce measurable cognitive benefits over two years in older adults at risk for Alzheimer's disease. The study highlights a critical gap between vascular risk reduction and brain health.

SourcePennington Biomedical Research Center·JournalJAMA Neurology·TypeRandomized controlled/clinical trial·DateMar 23, 2026

Gut microbiota and the gut–brain axis: Mechanisms and therapeutic hopes for brain diseases

The gut microbiota influences the central nervous system (CNS) through neural, immune, endocrine, and metabolic pathways. Dysregulation of this axis is linked to various neuropsychiatric and neurodegenerative disorders, including depression, schizophrenia, Alzheimer's disease, and Parkinson's disease.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateMar 19, 2026

New U of A study expands pesticide risk window to before pregnancy

A new University of Arizona study found that exposure to certain pesticides before pregnancy is associated with lower Apgar scores, a measure of newborn health. The study suggests that pesticides can affect the next generation, highlighting the importance of regulating pesticide use to improve maternal and child health.

SourceUniversity of Arizona·JournalJournal of Exposure Science & Environmental Epidemiology·TypeData/statistical analysis·DateMar 13, 2026

What changes happen in the aging brain?

Researchers created the most comprehensive single-cell atlas of epigenetic changes in the aging mouse brain, revealing how DNA methylation, genome structure, and gene activity change across brain regions and cell types. The atlas has already shown clear epigenetic differences between different age groups and allowed the development of ...

SourceSalk Institute·JournalCell·DateMar 11, 2026

Eyes as a window to hidden brain diseases

Researchers developed a fast, non-invasive, and affordable diagnostic tool using retinal images to differentiate between ALS and Alzheimer's disease. The tool, based on polarized light analysis, accurately predicted disease severity and type with high accuracy.

SourceUniversity of Waterloo·JournalAlzheimer’s & Dementia·TypeExperimental study·DateMar 11, 2026

Researchers clarify how ketogenic diets treat epilepsy, guiding future therapy development

A new review outlines the scientific explanations behind ketogenic diets' therapeutic benefits for epilepsy, including their ability to strengthen brain energy systems, reduce inflammation, and protect neurons. The review highlights the need for further research, particularly in adults, to develop new therapies that mirror the diet's e...

SourceUniversity of Colorado Anschutz·JournalThe Lancet Neurology·DateMar 11, 2026

New study on early Parkinson’s disease progression highlights vital role of patient focused drug development and real-world impacts

A new study found that functional impairment worsened over time in individuals with early Parkinson's disease, despite plateaued symptoms, with gait, balance, and posture being the most bothersome issues. The study's results underscore the importance of incorporating real-world measures of disease progression in clinical trial design.

Many patients want to talk about their faith. Neurologists often don't know how.

Patients with neurological diseases face profound questions about identity, purpose, and meaning, but neurologists often lack training and tools to address these concerns. A new paper offers practical strategies for incorporating spiritual assessment into routine neurological care.

SourceUniversity of California - Los Angeles Health Sciences·JournalNeurology Clinical Practice·TypeCommentary/editorial·DateMar 9, 2026

Temporal lobe epilepsy: A new strategy to correct abnormal electrical activity

Researchers have identified two compounds that restore chloride balance in neurons, thereby allowing GABAergic signaling to regain its inhibitory function. PCPZ and CLP-257 significantly improved KCC2 efficiency, reducing seizures and other electrical markers of epileptic activity in human brain tissue and animal models.

SourceInstitut du Cerveau (Paris Brain Institute)·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 6, 2026

Using the vagus nerve to treat disease: Review maps today’s science, points to tomorrow’s therapies

A comprehensive review synthesizes the science behind vagus nerve modulation therapies, which use controlled signals to influence brain circuits and inflammation. The authors identify key mechanisms and propose next-generation treatments tailored to individual patients and conditions.

SourceUniversity of California - San Diego·JournalComprehensive Physiology·TypeSystematic review·DateMar 5, 2026

Why does chronic back pain make everyday sounds feel harsher? Brain imaging study points to a treatable cause

A new study from CU Anschutz links chronic back pain to heightened brain responses to everyday sounds and finds that Pain Reprocessing Therapy can improve sensory amplification. The research found specific brain changes associated with sound hypersensitivity, which can be treated with psychological therapy.

SourceUniversity of Colorado Anschutz·JournalAnnals of Neurology·DateMar 2, 2026

Medicare patients get different stroke care depending on plan, analysis reveals

A study by University of Virginia Health System researchers found that Medicare Advantage patients had better access to preventive care and rehabilitation after a stroke, leading to faster recovery times. In contrast, traditional Medicare patients were less likely to receive these services due to prior authorization requirements.

SourceUniversity of Virginia Health System·JournalJournal of Comparative Effectiveness Research·DateFeb 18, 2026

Air pollution may directly contribute to Alzheimer’s disease

A large cohort study found that air pollution exposure increases the risk of Alzheimer's disease, particularly in individuals who have experienced a stroke. The study suggests that improving air quality could be an important way to prevent dementia and protect older adults.

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateFeb 17, 2026

AI model can read and diagnose a brain MRI in seconds

A new AI-powered model can read a brain MRI and diagnose neurological conditions with up to 97.5% accuracy, predicting treatment urgency and automating alerts for immediate medical attention. The technology has the potential to transform neuroimaging at health systems across the US, reducing workload and improving patient outcomes.

SourceMichigan Medicine - University of Michigan·JournalNature Biomedical Engineering·TypeComputational simulation/modeling·DateFeb 6, 2026

Chinese Medical Journal reports the safety and effectiveness of lecanemab in Chinese patients with early Alzheimer’s disease

The study found lecanemab to be safe and effective in slowing down cognitive decline and clearing brain Aβ deposition in Chinese patients with early AD. The results demonstrate a lower incidence of infusion-related reactions and amyloid-related imaging abnormalities compared to international clinical trials.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeRandomized controlled/clinical trial·DateFeb 6, 2026

Pregnancy, breastfeeding associated with higher levels of cognitive function for postmenopausal women

A new study by UCLA anthropology professor Molly Fox found that pregnancy and breastfeeding are associated with stronger long-term cognitive ability in postmenopausal women. The study used data from the Women’s Health Initiative Memory Study and the Women’s Health Initiative Study of Cognitive Aging, which assessed over 7,000 women age...

SourceUniversity of California - Los Angeles·JournalAlzheimer’s & Dementia·DateFeb 3, 2026

Backward walking study offers potential new treatment to improve mobility and decrease falls in multiple sclerosis patients

A study published in the Journal of Neurologic Physical Therapy found that backward walking training improved postural stability and gait speed in most participants with multiple sclerosis. The researchers suggest that this therapy may promote neuroplasticity and be a potential new treatment for improving mobility and decreasing falls.

SourceWayne State University - Office of the Vice President for Research·JournalJournal of Neurologic Physical Therapy·TypeExperimental study·DateFeb 3, 2026